The levels of mutant K-RAS and mutant N-RAS are rapidly reduced in a Beclin1 / ATG5 -dependent fashion by the irreversible ERBB1/2/4 inhibitor neratinib

por Booth, Laurence, Roberts, Jane L., Poklepovic, Andrew, Kirkwood, John, Sander, Cindy, Avogadri-Connors, Francesca, Cutler Jr, Richard E., Lalani, Alshad S., Dent, Paul
Publicado 2017